Aminobenzeensulfonzuurauristatine E

Aminobenzenesulfonic auristatin E is a agent-linker conjugate for ADC. Aminobenzenesulfonic auristatin E has potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic[1].

1800462-99-0

12352203

Drug-Linker Conjugates for ADC; Microtubule/Tubulin

ADC Related

Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton

Cancer-programmed cell death

Cancer

https://www.medchemexpress.com/aminobenzenesulfonic-auristatin-e.html

DMSO : 330 mg/mL (ultrasonic)

C[C@@H](C(N[S](=O)(C(C=C1)=CC=C1N)=O)=O)[C@H]([C@@](CCC2)([H])N2C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@@H](N(C)C)C(C)C)=O)=O)=O)OC

C37H64N6O8S

753.00

[1]Kevin HAMBLETT, et al. Anti-her2 biparatopic antibody-drug conjugates and methods of use. Patent WO2019173911A1.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-145989/

ADC Related

No Development Reported

Auristatin